
Rabenoj 20
January 14, 2025
CefProj 200
January 14, 2025Cefproj CV 325 Tablets is a combination of Cefpodoxime I.P. 200 mg and Clavulanate Potassium I.P. 125 mg, designed to treat a wide range of bacterial infections, including resistant strains. It works by inhibiting bacterial growth and enhancing antibiotic effectiveness.
Key Benefits
Effective against resistant bacterial infections
Broad-spectrum antibacterial action
Enhances antibiotic effectiveness
Provides fast relief from symptoms
Supports quicker recovery
Key Ingredients
Cefpodoxime 200 mg – Antibiotic that inhibits bacterial growth
Clavulanate Potassium 125 mg – Beta-lactamase inhibitor that prevents resistance
Indications
Respiratory tract infections
Urinary tract infections
Ear, nose, and throat infections
Skin and soft tissue infections
Gastrointestinal infections
Dosage
As directed by the physician
Usually taken once or twice daily
Precautions
Complete the full course of medication
Avoid if allergic to cephalosporins
Consult doctor if pregnant or breastfeeding
May cause mild side effects like nausea, diarrhea, or abdominal pain
Store in a cool and dry place
Keep out of reach of children
| Packing |
|---|





